Indian healthcare and wellness brand Kapiva, known for its modern take on Ayurvedic nutrition, has raised $60 million in a Series D funding round, marking a significant milestone in its growth journey.
The funding, led by 360 ONE Asset and Vertex Growth, also saw participation from existing investors like Vertex Ventures and 3one4 Capital, signaling strong confidence in Kapiva's vision.
Kapiva's Mission to Modernize Ayurveda
Founded with the aim of making Ayurveda accessible to millennials, Kapiva offers a range of natural and organic products targeting issues like diabetes, energy, sports nutrition, and heart health.
The brand has disrupted the traditional Ayurvedic market by presenting ancient remedies in convenient, modern formats, a strategy that has resonated with a growing consumer base.
Strategic Use of Funds for Innovation and Expansion
Kapiva plans to allocate the fresh capital towards research and development (R&D), enhancing manufacturing capabilities, and increasing brand investments to strengthen its market presence.
A key focus of this funding will be the development of a health-tech platform for personalized care, aiming to integrate technology with traditional wellness solutions.
Impact on the Indian Wellness Industry
This investment underscores the rising demand for holistic and natural health solutions in India, where the Ayurveda market is projected to grow at a CAGR of 15.32% through 2026.
Kapiva’s growth also highlights the potential for direct-to-consumer (D2C) brands to scale rapidly, with the company already present in over 40,000 offline stores alongside its robust online channels.
Historical Growth and Financial Milestones
Since its inception, Kapiva has shown impressive growth, with revenue doubling to Rs 114 crore in FY23, though it reported a widened net loss of Rs 64 crore during the same period.
The brand’s earlier funding rounds, including a $10 million raise led by OrbiMed Asia in 2024, have fueled its expansion and product innovation over the years.
Future Outlook and Global Ambitions
Looking ahead, Kapiva aims to achieve Rs 100 crore in global revenue within the next three years, capitalizing on the untapped potential of international markets for Ayurvedic products.
With this $60 million boost, Kapiva is poised to redefine wellness by blending ancient wisdom with cutting-edge technology, setting a benchmark for other Indian D2C brands on the global stage.
Andrew Lee
